Change in levels of C-reactive protein (CRP) and serum cortisol in morbidly obese patients after laparoscopic sleeve gastrectomy

Obesity Surgery

Volumn 23, Issue 6, 2013, Pages 764-769

  Ruiz Tovar, Jaime ^a,b,d   Oller, Inmaculada ^a   Galindo, Isabel ^a   Llavero, Carolina ^c   Arroyo, Antonio ^a,b   Calero, Alicia ^a,b   Diez, María ^a   Zubiaga, Lorea ^a   Calpena, Rafael ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c Hospital Sureste   (Spain)

^d NONE   (Spain)

Author keywords

C Reactive protein; Cortisol; Sleeve gastrectomy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMORBIDITY; CORRELATION ANALYSIS; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LAPAROSCOPIC SURGERY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; WEIGHT REDUCTION;

EID: 84878015230     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0865-7     Document Type: Article

References (24)

1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583-9.
2. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17:1063-71.
3. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey 1999 to 2004. J Am Coll Surg. 2008;207:928-34.
4. Zhang F, Strain GW, Lei W, et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2011;21:305-9.
5. Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopauseal females treated with restrictive bariatric surgery. World J Surg. 2011;35:2022-30.
6. Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:138-41.
7. Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, et al. Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex. BMC Cardiovasc Disord. 2012;12:37.
8. Klempfner R, Leor J, Tenenbaum A, et al. Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol. 2012;6:60.
9. Varghese B, Swamy S, Srilakshmi MA, et al. Visceral adiposity in young patients with coronary artery disease - a case control study. Indian Heart J. 2012;64:284-9.
10. Pasquali R, Vicennati V, Cacciari M, et al. The hypothalamic-pituitary- adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci. 2006;1083:111-28.
11. Walker BR. Cortisol - cause and cure for metabolic syndrome? Diabet Med. 2006;23:1281-8.
12. Reinher T, Andler W. Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004;62:107-12.
13. Gaziano JM, Hennekens CH, O'Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520-5.
14. Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg. 2012;256:1023-9.
15. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9.
16. Chen JY, Chou CH, Tsai WC, et al. Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease. J Am Soc Hypertens. 2012;6:253-60.
17. Aguilar Cordero MJ, González Jiménez E, Sánchez Perona J, et al. Obesidad y su relación con marcadores de inflamación y ácidos grasos de eritrocito en un grupo de adolescentes obesos. Nutr Hosp. 2012;27:161-4.
18. Stenholm S, Maggio M, Lauretani F, et al. Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANT study. Rejuvenation Res. 2010;13:3-11.
19. Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64:118-1189.
20. Rao SR. Inflammatory markers and bariatric surgery. Inflamm Res. 2012;61:789-807.
21. Nelson D, Porta R, Blair K, et al. The duodenal switch for morbid obesity: modification of cardiovascular risk markers compared with standard bariatric surgeries. Am J Surg. 2012;203:603-8.
22. Anagnostis P, Athyros VG, Tzionalos K, et al. The pathogenetic role of cortisol in the metabolic síndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692-701.
23. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report 2002. Circulation. 2002;106:3143-421.
24. Heneghan HM, Meron-Eldar S, Brethauer SA, et al. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108:1499-507.